Syner-Med Competitors and Similar CompaniesClear all
Syner-Med's competitors and similar companies include ZAI Lab, Delcath Systems, Photocure and Medexus Pharma.
 Syner-Med Syner-Med is a company dedicated to the development and marketing of pharmaceutical products, medical devices as well as licensing. |  ZAI Lab Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases. |  Delcath Systems Delcath Systems is a specialty pharmaceutical and medical device company focused on oncology. |  Photocure Photocure engages in the research, development, production, distribution of pharmaceutical products and related technical medical equipment. |  Medexus Pharma Medexus Pharma is a pharmaceutical company developing therapies for autoimmune diseases and cancer. | |
Founding Date | Founding Date 1995 | Founding Date 2014 | Founding Date 1988 | Founding Date 1997 | Founding Date 2012 |
Type | Type Private | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Purley, GB HQ Teteringen, NL | Locations CN HQ Suzhou, CN Hong Kong, HK Taipei, TW Cambridge, US Menlo Park, US | Locations New York, US HQ Galway, IE Queensbury, US | Locations Ullern, NO HQ Düsseldorf, DE Princeton, US | Locations Chicago, US HQ |
Employees | Employees 18 | Employees 1,869 | Employees 437% decrease | Employees 99 | Employees 106 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 3.2 b | Valuation ($) 294.6 m | Valuation ($) 127.5 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $460.2m (FY, 2025) | Revenue (est.) $85.2m (FY, 2025) | Revenue (est.) kr532.6m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $190.5m (FY, 2025) | Cost of goods $11.8m (FY, 2025) | Cost of goods kr29.2m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $269.6m (FY, 2025) | Gross profit $73.4m (FY, 2025) | Gross profit kr503.4m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income ($175.5m) (FY, 2025) | Net income $2.7m (FY, 2025) | Net income (kr1.5m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 985m | Total funding raised $ 42m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ZAI Lab
HQ
CN
Employees
1,869
Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases.
View companyDelcath Systems
HQ
New York, US
Employees
43↓ 7% decrease
Delcath Systems is a specialty pharmaceutical and medical device company focused on oncology.
View companyPhotocure
HQ
Ullern, NO
Employees
99
Photocure engages in the research, development, production, distribution of pharmaceutical products and related technical medical equipment.
View companyMedexus Pharma
HQ
Chicago, US
Medexus Pharma is a pharmaceutical company developing therapies for autoimmune diseases and cancer.
View company